Lipopolysaccharides

Displaying 1 - 8 of 8CSV
Schami, A., Islam, M. N., Wall, M., Hicks, A., Meredith, R., Kreiswirth, B., Mathema, B., Belisle, J. T., & Torrelles, J. B. (2024). Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-81457-0
Publication Date
Abhimanyu, Longlax, S. C., Nishiguchi, T., Ladki, M., Sheikh, D., Martinez, A. L., Mace, E. M., Grimm, S. L., Caldwell, T., Portillo Varela, A., Sekhar, R. V., Mandalakas, A. M., Mlotshwa, M., Ginidza, S., Cirillo, J. D., Wallis, R. S., Netea, M. G., van Crevel, R., Coarfa, C., & DiNardo, A. R. (2024). TCA metabolism regulates DNA hypermethylation in LPS andMycobacterium tuberculosis–induced immune tolerance. Proceedings of the National Academy of Sciences, 121(41). https://doi.org/10.1073/pnas.2404841121
Publication Date
Zhao, Y., Walker, D. I., Lill, C. M., Bloem, B. R., Darweesh, S. K. L., Pinto-Pacheco, B., McNeil, B., Miller, G. W., Heath, A. K., Frissen, M., Petrova, D., Sánchez, M.-J., Chirlaque, M.-D., Guevara, M., Zibetti, M., Panico, S., Middleton, L., Katzke, V., Kaaks, R., … Vermeulen, R. (2023). Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort. Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02846-2
Publication Date
Fernandes, H. B., de Oliveira, I. M., Postler, T. S., Lima, S. Q., Santos, C. A. C., Oliveira, M. S., Leão, F. B., Ghosh, S., Souza, M. C., Andrade, W., & Silva, A. M. (2023). Transcriptomic analysis reveals that RasGEF1b deletion alters basal and LPS-induced expression of genes involved in chemotaxis and cytokine responses in macrophages. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-47040-9
Publication Date
Ingham, M., Lee, S., Van Tine, B. A., Choy, E., Oza, J., Doshi, S., Ge, L., Oppelt, P., Cote, G., Corgiat, B., Sender, N., Sta Ana, S., Panchalingam, L., Petricoin, E., & Schwartz, G. K. (2022). A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical Cancer Research, 29(6), 1031–1039. https://doi.org/10.1158/1078-0432.ccr-22-3351
Publication Date
Islam, M. N., Gusarova, G. A., Das, S. R., Li, L., Monma, E., Anjaneyulu, M., Mthunzi, L., Quadri, S. K., Owusu-Ansah, E., Bhattacharya, S., & Bhattacharya, J. (2022). The mitochondrial calcium uniporter of pulmonary type 2 cells determines severity of acute lung injury. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33543-y
Publication Date
Ashraf, K. U., Nygaard, R., Vickery, O. N., Erramilli, S. K., Herrera, C. M., McConville, T. H., Petrou, V. I., Giacometti, S. I., Dufrisne, M. B., Nosol, K., Zinkle, A. P., Graham, C. L. B., Loukeris, M., Kloss, B., Skorupinska-Tudek, K., Swiezewska, E., Roper, D. I., Clarke, O. B., Uhlemann, A.-C., … Mancia, F. (2022). Structural basis of lipopolysaccharide maturation by the O-antigen ligase. Nature, 604(7905), 371–376. https://doi.org/10.1038/s41586-022-04555-x
Publication Date